Literature DB >> 2984106

A study of restriction fragment length polymorphisms at the human alpha-1-antitrypsin locus.

K J Matteson, H Ostrer, A Chakravarti, K H Buetow, W E O'Brien, A L Beaudet, J A Phillips.   

Abstract

A cloned cDNA for alpha-1-antitrypsin (alpha-1-AT) was selected from a human liver cDNA library. The identity of the clone was established by hybrid-selected translation and partial DNA sequencing. The cDNA was used as a probe to search for restriction site polymorphisms (RSPs) near the alpha-1-AT gene. Only two RSPs were found using 29 different restriction enzymes. Each of these polymorphisms resulted from the loss of a restriction site, one for EcoRI and the other for Taq I. The frequency of polymorphic restriction was calculated to be 1.1% to 2.6% of all sites tested, a figure lower than the 9.3% value observed for 12 RSPs in the human beta-globin gene cluster. Since the corresponding figure for detectable polymorphisms at the alpha-1-AT locus at the protein level is 12%, restriction enzymes are comparatively inefficient in detecting genetic variability. The basis of this inefficiency was studied by computing the nucleotide diversity from the RSP data. On the average, one in 500 to 1000 bases is polymorphic around the alpha-1-At locus. This value is comparable to that which we have calculated for the human beta-globin gene cluster and the human growth hormone gene cluster (both one in 500). These data demonstrate the limited usefulness of linked RSPs for genetic linkage studies at the alpha-1-AT locus.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2984106     DOI: 10.1007/bf00293037

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  45 in total

1.  Mathematical model for studying genetic variation in terms of restriction endonucleases.

Authors:  M Nei; W H Li
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

2.  Gene amplification causes overproduction of the first three enzymes of UMP synthesis in N-(phosphonacetyl)-L-aspartate-resistant hamster cells.

Authors:  G M Wahl; R A Padgett; G R Stark
Journal:  J Biol Chem       Date:  1979-09-10       Impact factor: 5.157

3.  Multiple, independent restriction site polymorphisms in human DNA detected with a cDNA probe to argininosuccinate synthetase (AS).

Authors:  S P Daiger; N S Hoffman; R S Wildin; T S Su
Journal:  Am J Hum Genet       Date:  1984-07       Impact factor: 11.025

4.  An efficient mRNA-dependent translation system from reticulocyte lysates.

Authors:  H R Pelham; R J Jackson
Journal:  Eur J Biochem       Date:  1976-08-01

5.  DNA polymorphism detectable by restriction endonucleases.

Authors:  M Nei; F Tajima
Journal:  Genetics       Date:  1981-01       Impact factor: 4.562

6.  Dispersion of argininosuccinate-synthetase-like human genes to multiple autosomes and the X chromosome.

Authors:  A L Beaudet; T S Su; W E O'Brien; P D'Eustachio; P E Barker; F H Ruddle
Journal:  Cell       Date:  1982-08       Impact factor: 41.582

7.  Cloning and sequence of cDNA coding for alpha 1-antitrypsin.

Authors:  K Kurachi; T Chandra; S J Degen; T T White; T L Marchioro; S L Woo; E W Davie
Journal:  Proc Natl Acad Sci U S A       Date:  1981-11       Impact factor: 11.205

8.  Polymorphism in the 5' flanking region of the human insulin gene: a genetic marker for non-insulin-dependent diabetes.

Authors:  P S Rotwein; J Chirgwin; M Province; W C Knowler; D J Pettitt; B Cordell; H M Goodman; M A Permutt
Journal:  N Engl J Med       Date:  1983-01-13       Impact factor: 91.245

9.  Molecular analysis of argininosuccinate synthetase deficiency in human fibroblasts.

Authors:  T S Su; H G Bock; A L Beaudet; W E O'Brien
Journal:  J Clin Invest       Date:  1982-12       Impact factor: 14.808

10.  Cloned human phenylalanine hydroxylase gene allows prenatal diagnosis and carrier detection of classical phenylketonuria.

Authors:  S L Woo; A S Lidsky; F Güttler; T Chandra; K J Robson
Journal:  Nature       Date:  1983 Nov 10-16       Impact factor: 49.962

View more
  9 in total

1.  Structure, evolution, and polymorphisms of the human apolipoprotein A4 gene (APOA4).

Authors:  S K Karathanasis; P Oettgen; I A Haddad; S E Antonarakis
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

2.  Mapping the gene for X-linked cataracts and microcornea with facial, dental, and skeletal features to Xp22: an appraisal of the Nance-Horan syndrome.

Authors:  R A Lewis
Journal:  Trans Am Ophthalmol Soc       Date:  1989

3.  Evidence for increased recombination near the human insulin gene: implication for disease association studies.

Authors:  A Chakravarti; S C Elbein; M A Permutt
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

4.  DNA polymorphism haplotypes of the human apolipoprotein APOA1-APOC3-APOA4 gene cluster.

Authors:  S E Antonarakis; P Oettgen; A Chakravarti; S L Halloran; R R Hudson; L Feisee; S K Karathanasis
Journal:  Hum Genet       Date:  1988-11       Impact factor: 4.132

5.  DNA restriction-site polymorphisms associated with the alpha 1-antitrypsin gene.

Authors:  D W Cox; G D Billingsley; T Mansfield
Journal:  Am J Hum Genet       Date:  1987-11       Impact factor: 11.025

6.  The X chromosome shows less genetic variation at restriction sites than the autosomes.

Authors:  M H Hofker; M I Skraastad; A A Bergen; M C Wapenaar; E Bakker; A Millington-Ward; G J van Ommen; P L Pearson
Journal:  Am J Hum Genet       Date:  1986-10       Impact factor: 11.025

7.  Deoxyribonucleic acid (DNA) polymorphism of the alpha 1-antitrypsin gene in chronic lung disease.

Authors:  N A Kalsheker; I J Hodgson; G L Watkins; J P White; H M Morrison; R A Stockley
Journal:  Br Med J (Clin Res Ed)       Date:  1987-06-13

8.  DNA polymorphisms of the human alpha 1 antitrypsin gene in normal subjects and in patients with pulmonary emphysema.

Authors:  I Hodgson; N Kalsheker
Journal:  J Med Genet       Date:  1987-01       Impact factor: 6.318

9.  Prenatal diagnosis of alpha 1 antitrypsin deficiency and estimates of fetal risk for disease.

Authors:  D W Cox; T Mansfield
Journal:  J Med Genet       Date:  1987-01       Impact factor: 6.318

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.